Reliability of the international normalized ratio for monitoring the induction phase of warfarin: Comparison with the prothrombin time ratio

Journal of Laboratory and Clinical Medicine

Volumn 128, Issue 2, 1996, Pages 214-217

  Johnston, M ^a   Harrison, L ^a   Moffat, K ^a   Willan, A ^a   Hirsh, J ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030205037     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90014-1     Document Type: Article

References (16)

1. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H. Oral anticoagulants: mechanism of action, clinical effectiveness and optimal therapeutic range. Fourth Annual ACCP Conference on Antithrombotic Therapy. Chest 1994;108:231S-46S.
2. Poller L, Taberner DA. Dosage and control of oral anticoagulants: an international survey. Br J Haematol 1982;51:479-85.
3. Bussey HI, Force RW, Bianco TM, Leonard AD. Reliance on prothrombin time ratios causes significant errors in anticoagulant therapy. Arch Intern Med 1992;152:278-82.
4. Kirkwood TBL. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemost 1983;49:238-44.
5. Poller L. A simple nomogram for the derivation of international normalised ratios for the standardisation of prothrombin time. Thromb Haemost 1988;60:18-20.
6. Hirsh J. Is the dose of warfarin prescribed by American physicians unnecessarily high? Arch Intern Med 1987;147: 769-71.
7. Hirsh J. The international normalized ratio. A guide to understanding and correcting its problems. Arch Intern Med 1994;154:282-8.
8. Ng VL, Levin J, Corash L, Gottfried EL. Failure of the international normalized ratio to generate consistent results within a local medical community. Am J Clin Pathol 1993; 99:689-94.
9. McKernan A, Thomson J, Poller L. The reliability of international normalized ratios during short-term oral anticoagulant treatment. Clin Lab Haemost 1988;10:63-71.
10. Loeliger EA, van der Esch B, Mattern MJ, Hemker HC. The biological disappearance rate of prothrombin, factors VII, IX and X from plasma in hypothyroidism and drug therapy. Thromb Diath Haemorrh 1964;10:267-77.
11. Hirsh J, Poller L, Deykin D, Levine MN, Dalen JE. Optimal therapeutic range for oral anticoagulants. Second Annual ACCP Conference on Antithrombotic Therapy. Chest 1989; 95:5S-11S.
12. Moriarty HT, Lam-Po-Tang PR, Anastas N. Comparison of thromboplastins using the ISI and INR system. Pathology 1990;22:71-6.
13. Poller L, Thomson J, Taberner DA. Effect of atuomation on the prothrombin time test in NEQAS surveys. J Clin Pathol 1989;42:97-100.
14. Poggio M, van den Besselaar AMHP, van der Velde EA, Bertina RM. The effect of some instruments for prothrombin time testing on the internationl sensitivity index (ISI) of two rabbit tissue thromboplastin reagents. Thromb Haemost 1989;62:868-74.
15. Ray MJ, Smith IR. The dependence of the international sensitivity index on the coagulometer used to perform the prothrombin time. Thromb Haemost 1990;63:424-9.
16. Poller L, Thomson JM, Taberner DA, Clarke DK. The correction of coagulometer effects on international normalized ratios: a multicentre evaluation. Br J Med 1994;86:112-7.